zoledronic acid has been researched along with Leukemia, Plasma Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kasinathan, G | 1 |
| Ameratunga, R; Chiu, W; Oei, P; Pullon, H; The, R; Woon, ST | 1 |
| Avcu, F; Nevruz, O; Pekel, A; Sengul, A; Ural, AU; Yalcin, A; Yilmaz, MI; Zerman, M | 1 |
3 other study(ies) available for zoledronic acid and Leukemia, Plasma Cell
| Article | Year |
|---|---|
Primary plasma cell leukaemia in a 39-year-old man.
Topics: Adult; Antineoplastic Agents; Bone Density Conservation Agents; Bone Marrow; Bortezomib; Dexamethasone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Immunoglobulin G; Immunoglobulin lambda-Chains; Immunosuppressive Agents; Leukemia, Plasma Cell; Male; Thalidomide; Zoledronic Acid | 2020 |
IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
Topics: Aged; Antineoplastic Agents, Alkylating; Bone Marrow Cells; Diphosphonates; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Imidazoles; Immunoglobulin A; Immunoglobulin E; Immunoglobulin kappa-Chains; Leukemia, Plasma Cell; Melphalan; Multiple Myeloma; Myeloma Proteins; Neoplasms, Second Primary; Prednisone; Zoledronic Acid | 2010 |
The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide.
Topics: Antineoplastic Agents; Apoptosis; Calcium; Cell Cycle; Cell Division; Dexamethasone; Diphosphonates; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Egtazic Acid; Enzyme Inhibitors; Humans; Imidazoles; Leukemia, Plasma Cell; Multiple Myeloma; Neoplasm Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Protein Kinase C; Staurosporine; Thalidomide; Tumor Cells, Cultured; Zoledronic Acid | 2003 |